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Abstract: The nearly-ubiquitous food and feed-borne mycotoxin aflatoxin B1 (AFB1) is carcinogenic
and mutagenic, posing a food safety threat to humans and animals. One of the most susceptible
animal species known and thus a good model for characterizing toxicological pathways, is the
domesticated turkey (DT), a condition likely due, at least in part, to deficient hepatic AFB1-detoxifying
alpha-class glutathione S-transferases (GSTAs). Conversely, wild turkeys (Eastern wild, EW) are
relatively resistant to the hepatotoxic, hepatocarcinogenic and immunosuppressive effects of AFB1
owing to functional gene expression and presence of functional hepatic GSTAs. This study was
designed to compare the responses in gene expression in the gastrointestinal tract between DT
(susceptible phenotype) and EW (resistant phenotype) following dietary AFB1 challenge (320 ppb for
14 days); specifically in cecal tonsil which functions in both nutrient absorption and gut immunity.
RNAseq and gene expression analysis revealed significant differential gene expression in AFB1-treated
animals compared to control-fed domestic and wild birds and in within-treatment comparisons
between bird types. Significantly upregulated expression of the primary hepatic AFB1-activating P450
(CYP1A5) as well as transcriptional changes in tight junction proteins were observed in AFB1-treated
birds. Numerous pro-inflammatory cytokines, TGF-β and EGF were significantly down regulated
by AFB1 treatment in DT birds and pathway analysis suggested suppression of enteroendocrine
cells. Conversely, AFB1 treatment modified significantly fewer unique genes in EW birds; among
these were genes involved in lipid synthesis and metabolism and immune response. This is the
first investigation of the effects of AFB1 on the turkey gastro-intestinal tract. Results suggest that in
addition to the hepatic transcriptome, animal resistance to this mycotoxin occurs in organ systems
outside the liver, specifically as a refractory gastrointestinal tract.
Keywords: Poultry; Turkey; Transcriptome; Aflatoxin B1; Cecal Tonsil; Cecum; RNAseq
Key Contribution: This study is the first to examine the transcriptome of the turkey cecal tonsil
region of gastro-intestinal tract. Importantly it combines RNAseq and gene expression analysis and
identifies key gene transcripts modulated in response to dietary AFB1 treatment.
1. Introduction
Aflatoxin B1 (AFB1) is a hepatotoxic, hepatocarcinogenic and immunosuppressive mycotoxin
commonly found in food and feed, especially corn [1]. Poultry are particularly sensitive to the toxic
effects of AFB1 and commercial domesticated turkeys are perhaps the most susceptible animal thus
far studied [2,3]. Exposure to AFB1 through contaminated feed is practically unavoidable and can
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result in reduced feed intake, weight gain and feed efficiency and increased mortality, hepatotoxicity
and GI hemorrhaging (reviewed in Monson et al. [4]). As a potent immunotoxin, AFB1 suppresses
cell-mediated, humoral and phagocytic immunological functions, thereby increasing susceptibility to
bacterial and viral diseases [5–7].
In contrast to their modern domesticated counterparts, wild turkeys are relatively resistant to
aflatoxicosis [8]. Metabolism of AFB1 requires bioactivation by hepatic cytochrome P450s (CYPs)
to the electrophilic exo-AFB1-8,9-epoxide (AFBO), which is catalyzed primarily, at pharmacological
concentrations by the high-efficiency CYP1A5 and to a minor extent by the lower-affinity CYP3A37
which predominates only at high, environmentally-irrelevant substrate concentrations [9]. In most
animals, AFBO is detoxified primarily by hepatic glutathione S-transferases (GSTs) [3]. The most
likely mechanism for the extreme susceptibility in domesticated turkeys is dysfunctional hepatic GSTs
rendering them unable to detoxify AFB1 [10–14]. In this regard, domesticated turkeys closely resemble
humans in that they also lack hepatic alpha-class GSTs (GSTA) with high activity toward AFB1 (seen in
mice and rats) suggesting that turkeys may represent a better model to study aflatoxin toxicology than
either of these rodent species [9]. Expression of GSTA in the intestine and the potential for extra-hepatic
bioactivation and metabolism of AFB1 in turkeys is unknown.
To better understand the response of the domestic turkey to AFB1 exposure, we initiated
transcriptomic analysis of AFB1-challenged domestic birds [15], where genes and gene pathways
in the liver were significantly dysregulated by dietary AFB1 challenge, such as pathways associated
with cancer, apoptosis, cell cycle and lipid regulation. These changes reflect the molecular
mechanisms underlying DNA alkylation and mutation, inflammation, proliferation and liver damage
in aflatoxicosis. Analysis of spleen tissues from the same birds examined in the Monson et al. [15] study
found that short AFB1 exposure suppressed innate immune transcripts, especially from antimicrobial
genes associated with either increased cytotoxic potential or activation-induced cell death during
aflatoxicosis [16].
The differential response of domestic and wild turkey to AFB1 was examined in a controlled
feeding trial [17]. Analysis by RNAseq of the hepatic transcriptome found genes dysregulated as a
response to toxic insult with significant differences observed between these genetically distinct birds in
the expression of Phase I and Phase II drug metabolism genes. Genes important in cellular regulation,
modulation of apoptosis and inflammatory responses were also affected. Unique responses in wild
birds were seen for genes that negatively regulate cellular processes, serve as components of the
extracellular matrix or modulate coagulation factors. Wild turkey embryos also showed differential
AFB1 effects compared to their commercial counterparts presumably due to lower levels of AFBO [18].
When treated with AFB1, embryos showed up-regulation in cell cycle regulators, Nrf2-mediated
response genes and coagulation factors [18]. Results of these studies supported the hypothesis that the
reduced susceptibility of wild turkeys is related to higher constitutive expression of GSTA3, coupled
with an inherited (genetic) difference in functional gene expression in domesticated birds.
The molecular basis for the differences in AFB1 detoxification observed between domesticated
commercial and wild birds has been extensively studied in our laboratories. However, extra-hepatic
effects, such as those occurring at the site of initial toxicant exposure, the intestine, are needed to fully
understand the systemic effects of AFB1 in this susceptible species. Unlike many mycotoxins, AFB1
is efficiently absorbed (>80%) in the avian upper gastrointestinal tract (GIT) [19]. Recent studies of
broiler chickens have found conflicting evidence for the potential impact of AFB1 on gut permeability,
from no effect [20] to increased permeability [21]. The avian small intestine is a primary site of nutrient
absorption [22] but is often overlooked from an immunological perspective. The cecal tonsils are the
largest aggregates of avian gut-associated lymphoid tissue, yet basic information on gene expression
in the cecal tonsil is lacking in the turkey. This study focused on the effects of dietary AFB1 on gene
expression in the turkey GIT and specifically the region at the junction of the distal ileum and cecum
(the cecal tonsil region) that functions in AFB1 absorption and gut immunity. The purpose of this study
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was to examine the transcriptomic response of the cecal tonsil region of the turkey intestine to dietary
AFB1 treatment and contrast these in susceptible (domesticated) and resistant (wild) birds.
2. Results
The effects of AFB1 on body weight and liver mass are summarized in a companion study of
hepatic gene expression [17]. Sequencing produced from 9.8M to 14.2M reads per library (average
12.7 million) (Table S1). Data are deposited in the NCBI’s Gene Expression Omnibus (GEO) repository
as SRA BioProject 346253. Median Q scores of the trimmed and filtered reads ranged from 36.5 to
37.7 among the forward and reverse reads. The number of reads per treatment group ranged from
10.9 to 12.8M with the mean number for EW birds being slightly higher than for the DT birds (12.6M
verses 11.2M). Over 90% of the quality-trimmed reads mapped to the annotated turkey gene set (NCBI
Annotation 101) and the vast majority of reads (average 85.2%) mapped concordantly (Table S1). Based
on mapping, the estimated mean insert size of the libraries was 195.4 ± 15.8 bp. Variation in mapped
reads among the treatment groups was visualized by PCA (Figure 1). Samples (AFB1 treatment/CNTL)
generally clustered distinctly by treatment group within the space defined by the first two principal
components. The exceptions were two EW AFB1 samples (EW1C and EW3C) that clustered with the
control birds. The relationships among groups was reiterated in the hierarchical clustering of groups
by Euclidean distance and heat map of co-expressed genes (Figure S1). This indicates the main effect
underlying this study is AFB1 treatment.
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genes (tRNAs excluded) with an average of 17,261 genes observed per individual (Tables S1, S2). 
When qualified (by-total normalized read count ≥ 3.0), the number of expressed genes averaged 
16,132 per individual (76.79% of the turkey gene set) with an average of 17,877 expressed genes per 
treatment group. The numbers of observed and expressed genes were higher for control groups than 
for AFB1-treatment groups of both EW and DT. A total of 16,097 genes (84.4%) was co-expressed 
among all groups and the number of co-expressed genes within the EW and DT lines was 17,833 and 
Figure 1. Principal component analysis (PCA) of by-total normalized RNAseq read counts. For each
treatment group, sample to sample distances (within- and between-treatments) are illustrated on the
first two principle components.
Evidence of expression (mapped reads ≥ 1.0 in at least one individual) was detected for
19,754 gen s (tRNAs excluded) with an average of 17,261 genes observed per indivi ual (Tables S1 and
S2). When qualified (by-total norm lized read count ≥ 3.0), the number of expressed genes averaged
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16,132 per individual (76.79% of the turkey gene set) with an average of 17,877 expressed genes per
treatment group. The numbers of observed and expressed genes were higher for control groups than
for AFB1-treatment groups of both EW and DT. A total of 16,097 genes (84.4%) was co-expressed
among all groups and the number of co-expressed genes within the EW and DT lines was 17,833 and
16,277, respectively (Figure 2). Each treatment group had a distinct set of uniquely expressed genes,
with the numbers being greater for the control groups (200 and 185) compared to the AFB1 groups
(80 and 113) (Figure 2).
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2.1. Differential Gene Expression
2.1.1. AFB1 Treatment Effects
The full list of genes showing significant differential expression (DE) in pairwise treatment
comparisons is provided in Table S3. I comparison of DT birds exposed to AFB1 (DTAFB) with
c ntrol-fed birds (CNTL) DE was observed for 11,237 genes in the cecal tonsil (FDR p-value < 0.05).
Of these, 7568 had |log2FC| > 1.0 and 4515 had |log2FC| > 2.0 (Table 1). The number of DE genes
was considerably fewer for the AFB1-treated EW turkeys (703 with FDR p-value < 0.05 and 687 e es
ith |log2FC| > 2.0). In DT birds, the majority (65.4%) of DEGs were down regulate (Figure 3)
although 48 of the 50 genes with the greatest fold change were up regulated (Table S4). In contrast,
98% of the DEGs in AFB1-treated EW birds were up regulated. Combined, 655 DEGs were shared
in comparisons for both bird types, with 3860 being unique to DT birds and 32 unique to EW birds
(Figure 3). Functional interpretation of many avian ge es is based on sequence and syntenic similarity
with human and ther model orga isms and therefore many functions are necessarily posited.
Shared Transcriptome Response
Among the 655 shared genes were the two phase I enzymes important in AFB1 metabolism
(Table S3). The first, CYP1A5 (cytochrome P450, family 1, subfamily A, polypeptide 5) was highly
up regulated in both EW and DT birds treated with AFB1 (log2FC = 7.66 and 9.67, re pectively).
Secondly, CYP3A37 (cytochrome P450 3A37) was significantly up regulated in only the DT birds
(log2FC = 2.73). Studies from our laboratory have identified these as the princ pal turkey hepatic
cytochromes responsible f r efficient epox dation of AFB1; CYP1A5 h s high st affini y toward AFBO
(low Km, high Vmax/Kcat) and bioactivates > 99% of AFB1 in turkey liver. In turkey, CYP3A37
(high Km, low Vm, Kcat) is only active at high environmentally-ir elevant substrate (i.e., AFB1)
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concentrations [9]. Although potential biochemical activity of GSTAs in the intestine (cecal tonsil) of
turkeys is unknown, expression of GSTA4 was significantly up regulated in both the EW and DT birds
with AFB1 exposure (log2FC = 4.53 and 5.89, respectively).



















CNTL) 18744 17833 402/509 703 703 687 674/13
DT (AFB vs.
CNTL) 18654 16277 304/2073 11237 7568 4515 1563/2952
Line
CNTL (EW
vs. DT) 18736 17956 386/394 679 348 67 37/30
AFB (EW
vs. DT) 18447 16369 1866/212 1666 1666 1410 1308/102
For each comparison, the treatment groups, total number of expressed, shared and unique genes, genes with
significant FDR p-value and the numbers of significant DE genes that also had |log2 fold change| >1.0 and >2.0
are given. For the DE genes with |log2 fold change| > 2.0 the number of genes up and down regulated are given.
Genes were considered expressed in a treatment group if by-total normalized read count ≥ 3.0 in any individual
within the group.
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Figure 3. Distribution of differentially expressed genes in the turkey. For each comparison, the number
of significant genes (FDR p-value < 0.05 and |log2FC| > 2.0) shared or unique to each treatment are
indicated in the Venn diagram. Circle size is proportional to the number of genes and direction of
expression change (↑ or ↓) is given for each group.
DE was also observed for several members of the claudin protein family. Claudins are integral
components forming the backbone of the tight junctions of epithelial and endothelial cells [23].
In EW birds, CLDN1 (claudin 1) was up regulated by AFB1 (log2FC = 4.55), whereas CLDN18 was
down regulated (log2FC = −6.57) (Table S3). In DT birds, CLDN1, CLDN2 and CLDN11 were up
regulated (log2FC = 6.04, 4.01 and 2.17, respectively) and CLDN3, CLDN10, CLDN19 and CLDN23
were down regulated (log2FC = −2.52, −7.17, −4.11, −8.05, respectively). Expression of other
key tight-junction proteins, tricellulin (MARVEL domain-containing protein 2, LOC104915344) and
occludin (LOC104915505), were also significantly altered in DT but with smaller fold changes (Table S3).
Upregulation of membrane tight-junction proteins such as claudins, is indicative of an epithelial
response in the gut lumen to AFB1 and may suggest that AFB1 could alter gut permeability and
perhaps stimulate a protective response in the gut to diminish mucosal inflammation/immune defense
and repair processes.
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Expression differences in CLDN1 observed in RNAseq read counts were further tested by qRT-PCR
where expression of CLDN1 transcripts was significantly higher in EW birds compared to controls
regardless of AFB1-treatment (Figure 4). Relative CLDN1 expression was also similarly variable in
other wild-type birds (Rio Grande Wild, RGW) where expression was comparable to that of EW birds
and significantly elevated with AFB1 treatment. Expression in other domestic birds (broad breasted
white, BB) was more similar to that of the wild birds than the Nicholas DT suggesting that the lower
CLDN1 expression observed in the Nicholas DT birds may have a genetic component.
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Figure 4. Effect of AFB1 on expression of genes in the IPA canonical pathway “GPCR-Mediated
Integration of Enteroendocrine Signaling Exemplified by an L Cell” in the cecal tonsil of turkeys (see
Figure 5).
Only two of the 655 shared DEGs (ATP12A and RSAD2) in the RNAseq data showed differences in
the directionality of expression. ATP12A (ATPase, H+/K+ transporting, non-gastric, alpha polypeptide)
was down regulated (log2FC = −2.83) in DT and up regulated (log2FC = 4.69) in EW birds. Similarly,
RSAD2 (radical S-adenosyl methionine domain containing 2) was down regulated (log2FC = −3.47)
in DT and up regulated (log2FC = 3.23) in EW. Two additional loci (SCD, stearoyl-CoA desaturase
[delta-9-desaturase]) and a ncRNA (LOC104914677) had a similar directional expression pattern, with
significant up regulation in EW with AFB1 treatment and down regulation in DT, however the log2FC
in the DT birds was below 2.0. ATP12A is a member of the P-type cation transport ATPase family and
in humans is involved in tissue-specific potassium absorption [24]. RSAD2 is an interferon inducible
antiviral protein and has been shown in human cell lines to inhibit secretion of soluble proteins [25].
In mammals, SCD has a regulatory role in the expression of genes involved in lipogenesis and is
important in mitochondrial fatty acid oxidation and energy homeostasis [26].
Nine of the 655 DEGs were significantly down regulated in both DT and EW with AFB1 treatment.
These included GGT1 (gamma-glutamyltransferase 1), OTOR (otoraplin), PLIN1 (perilipin 1), RSPH14
(radial spoke head 14 homolog), SLC34A2 (solute carrier family 34, member 2), LOC100550279 (fatty
acid-binding protein, adipocyte-like [FABP4-like]), LOC104909385 (erythroblast NAD(P)(+)–arginine
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ADP-ribosyltransferase pseudogene), LOC104913555 (gamma-glutamyltranspeptidase 1-like) and
TNFRSF13C (tumor necrosis factor receptor superfamily, member 13C). Genes of particular interest in
the GI tract include Perilipin 1 and fatty acid-binding protein (LOC100550279) that are involved in
lipid transport and metabolism in human adipocytes [27]. SLC34A2 is a sodium-dependent phosphate
transporter with an inverse pH dependence [28]. It is expressed in several mammalian tissues of
epithelial origin including lung and small intestine and may be the main phosphate transporter in the
brush border membrane. The B-cell activating factor TNFRSF13C is known to promote survival of
mammalian B-cells in vitro and is a regulator of the peripheral B-cell population [29].
Functional gene classification of the 655 shared DEGs with DAVID identified 10 enriched gene
clusters (Table S5). The cluster with the highest enrichment score included members of the serpin
family of protease inhibitors (SERPINA10, SERPINC1, SERPIND1, SERPINF2 and SERPING1) that
control many inflammation and coagulation processes. Other enriched clusters included complement
components, mannan-binding lectin serine peptidase 1 and 2 (MASP1, MASP2), the (C4/C2 activating
components) and coagulation factors F2, F7, F9 and F10. PANTHER overrepresentation tests
found greatest fold enrichment for biological processes indicative of the dual absorption/immunity
roles of the small intestine. Complement activation (GO:0001867) and regulation of intestinal
absorption (GO:1904729, 1904478, 0030300) were significantly enriched as was cholesterol homeostasis
GO:0042632) as exemplified by up regulation of several genes (ABCG5, ABCG8, ANGPTL3, APOA1,
APOA4, APOA5, CETP, EPHX2, G6PC, LIPC and LPL).
Unique Transcriptome Responses
Domesticated birds showed the greatest AFB1 gene response with 3860 unique DEGs (Figure 3).
Genes showing the highest differential response (Table S4) were enriched for those encoding proteins
with signal peptides and Serpins. DEGs with the greatest up regulation included INHBC (inhibin, beta
C, log2FC = 13.63), claudin-19-like (LOC100544298, log2FC = 12.56), TTC36 (tetratricopeptide repeat
domain 36, log2FC = 12.28) and three ncRNAs (LOC104913410, LOC104915491, LOC10491649, log2FC
=12.74 to 13.15), SMIM24 (small integral membrane protein 24, log2FC = −12.48) and SLC10A2 (solute
carrier family 10 [sodium/bile acid cotransporter], member 2, log2FC = −12.07). Expression of GSTA3
was significantly lower in DT birds treated with AFB1 compared to controls (log2FC = −2.33). Other
αGSTs (GSTA1 and GSTA2) were significantly up regulated but with lower fold change (log2FC < 2.0,
Table S3).
Over 650 of the 3860 DEGs were functionally clustered (DAVID enrichment score 24.96) as having
membrane or transmembrane UniProt keywords. The majority of these (518, 77.9%) were down
regulated as an effect of AFB1 treatment. Several alpha-1-antitrypsin-like loci were significantly up
regulated consistent with a response to acute inflammation. Analysis of the 3860 unique genes in
IPA found the most significant canonical pathways to be Axonal Guidance Signaling (-log(p-value)
= 8.65), Hepatic Fibrosis / Hepatic Stellate Cell Activation (8.24), GPCR-Mediated Integration of
Enteroendocrine Signaling Exemplified by an L Cell (7.33) and Calcium Signaling (7.28). DEGs in these
pathways were almost exclusively down regulated in AFB1-treated birds. This effect is dramatically
illustrated for the in the IPA canonical pathway “GPCR-Mediated Integration of Enteroendocrine
Signaling Exemplified by an L Cell” (Figure 5) suggesting suppression in domesticated birds of
enteroendocrine cells that produce and release gastrointestinal hormones such as glucagon-like
peptides, peptide YY and oxyntomodulin that participate in nutrient sensing and appetite regulation
and peptides to activate nervous responses [30].
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Figure 5. Differential expression of genes in the IPA canonical pathway “GPCR-Mediated Integration
of Enteroendocrine Signaling Exemplified by an L Cell.” Genes with significantly lower expression in
domesticated turkeys relative to Eastern wild birds after AFB1 treatment are denoted in green. Genes
tested by qRT-PCR are outlined in orange (Figure 4).
Differential expression differences in genes of the “GPCR-Mediated Integration of
Enteroendocrine Signaling Exemplified by an L Cell” pathway observed in RNAseq read counts
were further tested in eight genes by qRT-PCR. These included ADCYAP1 (adenylate cyclase
activating polypeptide 1), CCKAR (cholecystokinin A receptor), GALR1 (galanin receptor 1), GLP2R
(glucagon-like peptide 2 receptor), GRPR (gastrin-releasing peptide receptor), NMB (neuromedin B),
NPT2R (neuropeptide Y receptor Y2) and VIPR1 (LOC100303683, vasoactive intestinal polypeptide
receptor). With the exception of VIPR1, each of these genes showed lower expression in AFB1-treated
DT birds as compared to treated EW birds. The VIPR1 receptor was selected as it is downstream of
two affected genes (ADCYAP1 [PACAP] and VIP) in the pathway. With the exception of NMB and
VIPR1, expression of the selected genes in EW birds was greater than in DT (domestic Nicholas turkey)
consistent with RNAseq results (Figure 4). Disparate results between qRT experiments and RNAseq
may be attributed to the higher efficiency of qRT-PCR in sampling genes with low average expression
such as NMB. In the case of ADCYAP1, CCKAR and GRPR expression was also greater in the untreated
EW birds relative to untreated DT birds. As expected, little variation was observed in VIPR1. Relative
expression of these genes was also tested in the other commercial-type (broad-breasted white, BB)
and wild-type birds (Rio Grande subspecies, RGW). Comparable expression results were seen for
ADCYAP1 and GRPR. Expression of 3 genes in the BB birds (CCKAR, GALR1 and NPY2R) was elevated
as compared to the DT group with levels more similar to the EW and RGW groups (Figure 4).
Only 32 DEGs were found unique to the wild turkey in the AFB1 versus CNTL RNAseq
comparison (Figure 3). The majority (28, 87.5%) were up regulated in the AFB1-treated birds. Included
among these are genes involved in lipid synthesis and metabolism (exemplified by ACSBG2, ANGPTL4
and SCD) and immune response (IRG1 [immunoresponsive 1 homolog], PI3 [peptidase inhibitor 3]).
A single annotation cluster (GO:0016021 integral component of membrane) was identified in DAVID
that included 5 genes (CLDN18, FAXDC2, PTPRQ, SCD and SLC23A1). Interestingly, 29 of the 32
unique genes were also DE in the liver transcriptomes obtained from the same individuals [17] but
showed opposite directional change in response to AFB1.
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2.2. Wild versus Domesticated Turkey
2.2.1. Control Birds
Comparison of the transcriptomes of EW and DT birds in the control groups found 679 DEGs
(FDR p-value < 0.05, log2FC = −7.882 to 6.715, Table 1 and Table S3), with 67 having |log2FC| > 2.0
(Figure 6, Table S6). Of the 67 genes, 13 were shared in common in the EW versus DT AFB1
comparisons (Figure 6). The shared loci included 7 genes up regulated in EW birds; (CAMK4
[calcium/calmodulin-dependent protein kinase IV], LOC100548321 [Pendrin], NEFM [neurofilament,
medium polypeptide], LOC104914065 [pendrin-like] LINGO2 [leucine rich repeat and Ig domain
containing 2], LOC100538933 [probable ATP-dependent RNA helicase DDX60] and the uncharacterized
LOC100549340 [ncRNA]). This differential expression may have implications for both epithelial
function and inflammatory response. For example, as an anion exchange protein, Pendrin may function
to regulate active chloride transport across epithelial membranes as a chloride-formate exchanger [31].
CAMK4 is implicated in transcriptional regulation in immune and inflammatory responses [32] and
DDX60 is thought to positively regulate DDX58/RIG-I- and IFIH1/MDA5-dependent type I interferon
and interferon inducible gene expression [33].
Down regulated genes among the 13 shared DE loci in the EW/DT comparison
included LOC100540418 (BPI fold-containing family C protein-like [BPIFC]), LOC104915630
(3 beta-hydroxysteroid dehydrogenase/Delta 5–>4-isomerase-like [HSD3B1]), LOC104917314 (14-3-3
protein gamma-B) and 3 uncharacterized ncRNA loci. Two of these genes have direct implication
in gut homeostasis. BPIFC is a lipid transfer/lipopolysaccharide binding protein that may help
provide defense against microorganisms [34]. In humans, HSD3B1 is an important gene in the
biosynthesis of hormonal steroids as it catalyzes oxidative conversion of delta-5-3-beta-hydroxysteroid
precursors. Altered expression of hormones in the gut may directly influence gene expression in the
gut microbiota [35].
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Figure 6. Distribution of differentially expressed genes between turkey types (wild and domesticated).
For each comparison, the number of significant genes (FDR p-value < 0.05 and |log2FC| > 2.0 shared
or unique to each treatment group are indicated. Circle size is proportional to the number of genes and
direction of expression change (↑ or ↓) is given for each group.
Of the 54 DEGs unique to the control group birds slightly more (55%) were up regulated in the
EW birds compared to the DT birds (Table S6). These 54 unique DEGs included integral membrane
proteins (e.g., AQP10), cytoplasmic enzymes (NME8), nuclear transcriptional regulators (HOXB5) and
secretory proteins (GKN2) that are typical of intestinal epithelium but without significant enrichment
for any particular biological process. Greatest differential expression was seen for claudin 18 (CLDN18),
a membrane protein that is a component of tight junction strands with higher expression in EW
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(log2FC = 6.72) than DT. Also represented were genes with immune system roles such as DNTT (DNA
nucleotidylexotransferase), which functions in generating antigen receptor diversity and NOS1 (nitric
oxide synthase 1), a host defense effector with antimicrobial activity.
2.2.2. AFB1 Treatment
The greatest number gene expression differences observed between the EW and DT birds occurred
in the AFB1-treatment groups. A total of 1666 DEGs (FDR p-value < 0.05) were observed with 1410
having |log2FC| > 2.0 (Table 1). As discussed above, 13 DEGs were shared with the control comparison
and 1397 were unique (Figure 6, Table S7). Interestingly, 93% of the DEGs showed higher expression
in the EW birds compared to DT. Non-coding RNAs comprised 29.4% of the down regulated genes
(n = 30) and 5% of the up regulated DEGs (n = 66). Greatest differential expression (up regulation) in
EW compared to DT was seen for LOC104912821 (ovostatin homolog, log2FC = 11.84), LOC104915655
(alpha-2-macroglobulin, A2M, log2FC = 11.4) and genes such as SLC10A2 (solute carrier family 10
[sodium/bile acid cotransporter] member 2, log2FC = 11.06) and FABP6 (fatty acid binding protein 6,
log2FC = 10.26). Ovostatin and A2M both have endopeptidase inhibitor activity, whereas SLC10A2 and
FABP6 function in bile acid metabolism. Greatest down regulation in EW compared to DT was seen
for GYG2 (Glycogenin 2, log2FC = −7.19) and LOC104916581 (7-dehydrocholesterol reductase-like,
log2FC = −5.56). In humans, GYG2 is expressed mainly in the liver and heart and is involved in
initiating reactions of glycogen biosynthesis; 7-dehydrocholesterol reductase is ubiquitously expressed
and helps catalyze the production of cholesterol [36,37].
Functional analysis of the 1397 unique DEGs in DAVID found highest enrichment score (14.11) for
the annotation cluster “Membrane” (p = 4.1 × 10−16), which included 284 genes (Table S7). The second
annotation cluster (enrichment = 5.39) contained 50 genes with immunoglobulin-like domains or Ig-like
fold (homologous superfamily IPR013783, p = 5.7× 10−7). Included were several complement proteins,
interleukins and Ig superfamily members (Table S7). Additional clusters identified in DAVID included
“extracellular exosome” (136 DEGs, p = 6.5 × 10−3) and “signal” (118 DEGs, p = 2.3 × 10−8). Calcium
signaling was the most expressively represented Kegg pathway containing 29 DEGs (p = 1.8 × 10−6,
Figure S2), followed by “Focal adhesion” (28 DEGs, p = 6.1 × 10−4) and “Neuroactive ligand-receptor
interaction” (28 DEGs, p = 7.4 × 10−2).
Among the 1397 unique DEGs were two olfactory receptor genes, LOC100546335 (OR51E2-like)
and LOC1005546179 (OR51G2-like). Both of these loci were up regulated in the EW birds compared
to DT with AFB1-treatment (log2FC = 8.15 and 8.46, respectively). Expression of functional taste
and olfactory receptors has been observed in human enteroendocrine cells [38,39] and a survey of
RNAseq data from multiple human tissues identified expressed olfactory receptors with broad and
tissue-exclusive expression [40]. An interesting aspect of LOC100546335 and LOC1005546179 is that
based on read count, expression of both loci was roughly similar. These loci are adjacent in the
turkey genome and are annotated as sharing two non-coding 5′ exons (Figure 7). A total of seven
transcript variants for the two genes were predicted by NCBI’s automated computational analysis
gene prediction method (Gnomon). Examination of RNAseq reads from 3 individuals in the present
study (EW1, EW9 and NC11) found split RNAseq reads (intron spanning) that support each of the
predicted variants with the exception of the variant 51E2- -X4. However, RNAseq reads did map to the
non-coding upstream (5′) exon of variant 4 (Figure 7). Interestingly, split reads were also identified in
each individual that indicated splicing events between the two small 5′ exons, not predicted in the
NCBI models.
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3. Discussion
Naturally-occurring dietary toxins such as AFB1 pose significant public health risk throughout
the world but especially in locales characterized by high contamination levels of dietary staples such
as corn. One of most significant is AFB1 which primarily targets the liver, the organ with the highest
concentration of bioactivating CYPs. Extra-hepatic metabolism and bioactivation of this mycotoxin is
a much-studied topic [41] but comparatively few studies have focused on the gastrointestinal tract,
even though dietary exposure is the principal route for people and animals. Conversion of AFB1 to the
AFBO epoxide has been implicated in the rat intestine [42] and even nasal mucosal cells [43]. Studies
of cultured human intestinal epithelial cells (Caco-2) found AFB1 decreases trans-epithelial electrical
resistance (TEER) [44]. Similarly, Romero et al. [45] reported that AFB1 treatment caused a reduction in
TEER and mitochondrial viability and increased cell permeability. By contrast, the detoxified AFB1
metabolite AFM1 did not permanently compromise the integrity of Caco-2 cells grown on microporous
filter supports [46]. In poultry, AFB1 is efficiently absorbed in the upper GI tract and thus exposure of
the intestinal mucosa is greater than in other organs. While we have not quantified AFB1 bioactivation
in the turkey gut, expression of the primary hepatic AFB1-activating CYP1A5 was highly upregulated
by AFB1 in the turkey cecum. Increased CYP1A5 expression in AFB1-treated turkeys was also observed
in the liver [17] and is a common observation in animals, as this and other CYPs are known to be
induced by AFB1 and other foodborne and environmental toxicants [47]. Similarly, expression of
GSTAs (particularly GSTA4), were up regulated by AFB1. In contrast, a prior study found expression
of GSTAs in the liver were oppositely affected; GSTA1, GSTA2 and GSTA4 were down regulated after
2 weeks exposure to AFB1 and expression of GSTA3 was significantly lower in EW birds compared to
DT after AFB1 treatment [17].
The gastrointestinal epithelium provides an important physical barrier to foreign antigens and
pathogens and disruptions thereof are increasingly associated with diseases [48]. Although few studies
have specifically investigated the ability of aflatoxin to compromise intestinal permeability [19,49],
the potential for mycotoxins to cause dysfunction of the intestinal barrier has come under increased
study. Mycotoxins modulate the composition of gut microbiota, often eliminating beneficial bacteria,
which leads to increased colonization by gut pathobionts and pathogens [50,51]. Exposure to AFB1 has
been shown to induce changes in gut microbiota in rodents [52,53] and to modify barrier function in
intestinal epithelial cells [49]. Probiotic gram-positive strains of Lactobacillus, Propionibacterium and
Bifidobacterium have been proposed as feed additives to attenuate AFB1-induced toxicity in poultry
due to their ability to bind AFB1, thereby reducing its bioavailability [54–57]. Gene expression
in AFB1-treated birds is modulated by probiotics but the negative effects of AFB1 are not fully
mitigated [15,16]. It is possible that in addition to binding AFB1, these probiotics exert positive
effects by acting to decrease gut permeability and other protective functions [58].
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Of interest in the present study is the potential of AFB1 to disrupt tight junction proteins allowing
for increased translocation of substances from the lumen to the blood and lymphatic circulation [49].
Transmembrane tight junctions consist of claudins, occludin, tricellulin and a group of junction
adhesion molecules that form the horizontal barrier at the apical lateral membrane [59]. Claudins are a
family of transmembrane proteins that are essential components in the apical junctional complex of
epithelia and endothelia cells [60], the expression of which in humans, is modulated by aflatoxins [45,
61]. Romero et al. [45] found dose-dependent down regulation in CLDN3 and occludin in human
Caco-2 cells treated with AFB1 consistent with an observed decrease in gut barrier properties. Gao et
al. [61] found decreased expression of TJ proteins (CLDN3, CLDN4, occludin and zonula occludens-1)
and disrupted structures following exposure to aflatoxin M1 (4-hydroxylated metabolite of AFB1).
Dietary AFB1 treatment in the present study elicited transcriptional changes in several claudin
transcripts including up regulation of CLDN1 in both EW and DT, down regulation of CLDN3 in
DT, down regulation of CLDN18 in EW and up regulation of CLDN10 and CLDN23 in EW birds.
Transcriptional modifications of claudins may indicate a response to restore impaired TJ proteins and
potentially compromised gut permeability. In vivo studies in poultry have produced inconsistent
results. In broilers, AFB1 increased gut permeability as measured by the serum lactose/rhamnose ratio
(dual sugar test), as well as increases in expression of CLDN1, multiple jejunal amino acid transporters
and the translation initiation factor 4E [21]. A second study [20] found no evidence for increased
gut permeability in broilers as measured by GI leakage of FITC-d following exposure to varying
concentrations of AFB1. Annotation of avian claudin genes is based on similarities to mammalian
orthologs and in many cases function has not been experimentally demonstrated. Results of the present
study indicate that additional studies of the effect of AFB1 on gut permeability in turkey are needed.
Exposure to AFB1 has widespread adverse physiologic effects. In poultry, AFB1 adversely
affects production characteristics causing poor performance, decreased growth rate, body weight,
weight gain, egg production, reproductive performance and feed efficiency [62]. Humoral and
cell-mediated immune functions in poultry are also impaired by AFB1 in keeping with its well-known
immunotoxicity [3,5,6,16,41,63–65]. Altered humoral response to fowl cholera and Newcastle Disease
(ND) virus has been described in chickens where correlation was observed between outbreaks of
ND and AFB1-contaminated feeds (reviewed in Reference [65]). Effects on cell-mediated immunity
are evident as decreased phagocytic activity in leukocytes [66–69]. Exposure to AFB1 in turkeys
causes suppression of humoral and cellular immunity resulting in compromised immune response in
hatchlings making them more susceptible to disease [6]. In this respect, AFB1 is a “force-multiplier”
synergizing the adverse effects of other agents and pathogens detrimental to poultry health.
Compromised epithelial barrier is associated with increased paracellular permeability that
may lead to overstimulation of the gut immune system and a non-specific systemic inflammatory
response [48,70]. The cecal tonsil is the major lymphoid tissue in the avian cecum that provides
important and unique immune functions. Detailed studies in poultry have demonstrated impairment
of the normal function of the cecal tonsil caused by AFB1 through depletion of lymphocytes and lesions
in the absorptive cells [71]. AFB1 significantly decreases intestinal IgA(+) cells and the expression
of immunoglobulins in the intestinal mucosa [72]. Dietary AFB1 exposure decreases cell-mediated
immunity while inducing the inflammatory response. Immune activation and inflammation result in
mucosal recruitment of activated cells, modulated by cytokines. Cytokine-mediated dysfunction of
tight junctions is important in gastrointestinal disease [48] as cytokines and other growth factors may
act to alternatively decrease (e.g., IL-10) or increase (e.g., IL-6) gut permeability [58]. In the commercial
DT birds, numerous pro-inflammatory cytokines, TGF-β and EGF were significantly down regulated
by AFB1 treatment. In contrast, the interleukin 6 (IL6R) and interleukin 13, alpha 2 (IL13RA2) receptors
and the interleukin 1 receptor accessory protein (IL1RAP) were significantly up regulated in both EW
and DT birds. In humans, IL13RA2 functions to internalize the immunoregulatory cytokine IL-13.
Dysregulation of IL6 impacts CLDN2 expression (significantly up regulated by AFB1 in DT in this
study) and can undermine the integrity of the intestinal barrier [73].
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In response to the luminal environment, chemical receptors of intestinal epithelial and
neuroendocrine cells modulate the function of these cells and ultimately systematic metabolism
and homeostasis [38,74]. For example, ingestion of food results in signaling to the brain to regulate
food intake and detection of bacterial metabolites may induce host defense responses. Part of this
gut-brain axis is performed by enteroendocrine L-cells with specific nutrient-sensing receptors [30].
These include intestinal olfactory receptors that recognize ingested odor compounds and alter glucose
homeostasis through induced secretion of gut-peptides [75]. In pigs, the olfactory receptor OR51E1
has been localized to enteroendocrine cells along the GI tract. Expression of the gene encoding this
receptor was significantly altered following modulation of the intestinal microbiota, presumably in
response to microbial metabolites [76]. Differential expression of OR genes in the turkey GIT may be
caused by a direct action of AFB1 on the intestinal epithelial cells or secondarily through changes in
the intestinal microbiota induced by AFB1.
Intensive breeding and genetic selection to produce the modern domesticated turkey has
dramatically affected performance metrics. For example, growth rate to market age has essentially
doubled in the past 40 years and feed efficiency of contemporary tom turkeys is approximately
50% better when compared to non-growth selected birds fed modern diets [77]. Under normal
conditions, commercial birds typically reach 19 lbs. by 20 weeks of age, with a feed conversion ratio
of approximately 2.5 [78]. Our results suggest that selection for production traits, such as increased
nutrient conversion, may have contributed to the extreme sensitivity of DT to AFB1. In the same
way, the relative resistance of WT, in addition to expression of AFB1-detoxifying GSTAs, may also
involve extra-hepatic mechanisms such as a more refractory gastrointestinal tract, in addition to the
presence of functional hepatic GST-mediated AFB1 detoxifying capability [12,13]. Possibly related to
this, studies of production performance in chickens suggest that sensitivity to AFB1 has increased since
the 1980s, concomitant with industry selection for increased nutrient conversion and demands for
greater metabolism (reviewed in Yunus et al. [65]). Elucidation of extra-hepatic routes of pathogenesis
provides a clearer picture of the complexity of species resistance and susceptibility to this potent
mycotoxin that may also suggest analogous mechanisms in humans.
4. Materials and Methods
This study used turkeys previously found to vary in AFB1-detoxifying GST activity. Animal
husbandry and the AFB1 protocol were as described in Reed et al. [17]. Birds included AFB1-treated and
control animals from the Eastern Wild (EW, Meleagris gallopavo silvestris) subspecies and domesticated
Nicholas turkeys (DT). Male turkey poults were subjected to a short-term AFB1-treatment protocol in
which the diet of challenge birds was supplemented beginning on day 15 of age with 320 ppb AFB1
and continued for 14 days. Previous studies with higher AFB1 dosing (1 ppm) caused an unacceptable
mortality rate. Birds serving as experimental controls received a standard AFB1-free diet. At the end
of the trial, birds were euthanized and a section of the cecum corresponding to the cecal tonsil was
removed and placed in RNAlater (ThermoFisher Scientific, Waltham, MA, USA) for RNA isolation
and RNAseq analysis. All procedures were approved by Utah State University’s Institutional Animal
Use and Care Committee (Approval #2670, date of approve: 26 September 2016).
4.1. RNA Isolation and Sequencing
Total RNA was isolated from cecal tonsils by TRIzol extraction (ThermoFisher), treated with
DNAse (Turbo DNA-freeTM Kit, ThermoFisher) and stored at −80◦ C. Library preparation and
sequencing was performed at the University of Minnesota Genomics Center. Briefly, concentration
and quality of RNA was assessed on a 2100 Bioanalyzer (Agilent Technologies) and RNA Integrity
Numbers (RIN) averaged 6.7. Replicate samples (n = 4) from each treatment group were examined.
Indexed libraries (n = 16) were constructed, multiplexed, pooled and sequenced (101-bp paired-end
reads) on the HiSeq 2000 using v3 chemistry (Illumina, Inc., San Diego, CA, USA). Sequence reads
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were groomed, assessed for quality and mapped to turkey genome (UMD 5.0, NCBI Annotation 101)
as described in Reed et al. [17].
4.2. Quantitative Real-Time PCR
Quantitative real-time PCR (qRT-PCR) was performed on both domesticated and wild turkeys.
Samples included the Eastern Wild (EW; M. g. silvestris) and domesticated Nicholas turkey (DT)
birds, plus domesticated Broad Breasted White (BB) and birds of the Rio Grande subspecies of wild
turkey (RGW; M. g. intermedia) from a parallel AFB1-challenge experiment. Of the 6 samples from
the DT and EW groups used for qRT-PCR, four were in common with the RNAseq study. Synthesis
of cDNA was performed on DNase-treated mRNA using Invitrogen Super Script IV First-strand
synthesis kit (Invitrogen, Carlsbad, CA, USA). The iTaq Universal SYBR Green Supermix (BioRad,
Hercules, CA, SA) was used for quantitative analysis of gene-specific amplicons with the CFX96
touch real time detection system (BioRad, Hercules, CA, USA). Primers were designed using the
turkey genome sequence (UMD5.0) and Primer3 software [79]. Primer sets were designed so the
amplicon spanned an exon/exon junction and at least one intron. Several normalizing genes were
tested for uniformity and the most stable reference gene (hypoxanthine guanine phosphoribosyl
transferase, HPRT) was determined with RefFinder [80]. Target gene reactions were conducted in
triplicate and HPRT normalization reactions, no template and gDNA controls were run in duplicate.
Disassociation curves were used to confirm single product amplification and to preclude the possibility
of dimer amplification.
4.3. Statistical Analysis
For expression analysis of RNAseq data, read counts were by-total normalized and expressed
as reads per 11.9M (CLC Genomics Workbench v. 8.0.2, CLC Bio, Aarhus, Denmark). Principal
component analysis (PCA) and hierarchical clustering of samples based on Euclidean distance was
performed (with single linkage) in CLCGWB using by-total normalization. Empirical analysis of
differential gene expression (EdgeR) and ANOVA were performed in CLCGWB on mapped read
counts with TMM (Trimmed Mean of M-values) normalization (Bonferroni and FDR corrected).
Pair-wise comparisons between treatment groups were made following the standard workflow Wald
test. Significant differentially expressed (DE) genes were used to investigate affected gene pathways
with Ingenuity Pathway Analysis (IPA) (Ingenuity Systems, Redwood City, CA, USA). Gene Ontology
(GO) and functional classification was performed in DAVID (v6.8, [81]) and overrepresentation tests for
gene enrichment were performed with PANTHER (GO Consortium release 20150430) [82]. For analysis
of qRT-PCR data, expression was normalized first to HPRT, then interpreted using the Double Delta Ct
Analysis (∆∆Ct, [83]) and a comparative Ct approach. Expression analysis was performed using the
standard ∆∆Ct workflow within the CFX Maestro software package (Biorad, Hercules, CA, USA).
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DT domesticated turkey
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PCA principal component analysis
qRT-PCR quantitative real-time polymerase chain reaction
RGW Rio Grande wild turkey (Meleagris gallopavo intermedia)
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